Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
Recruiting now · Phase 1
Conditions studied: Hematologic Malignancies
In brief
The purpose of this phase 1 study is to determine the optimal dose of the immune suppressive drug, cyclophosphamide, following standard allogeneic stem cell transplant in patients aged \>/= 65 years with hematologic malignancies.
Key facts
- Study ID
- NCT05849207
- Run by
- Ronald Paquette
- People needed
- 26
- Starts
- 2023-10-24
- Expected to finish
- 2028-07-01
- Last updated by the study team
- 2026-08-05
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient age >/= 65 years
- Patient and related Donor (if applicable) sign the Informed Consent Form for the study. If donor is unrelated, donor does not sign Informed Consent Form and this will not affect recipient study eligibility.
- Patient meets standard criteria for allogeneic stem cell transplant
- Patient is deemed suitable to receive Flu/TBI 800 conditioning regimen as standard of care transplant
- Donor is willing to donate peripheral blood stem cells
You may not qualify if…
- Patient has a diagnosis of myelofibrosis
- Patient has high titer antibodies (>10,000 mean fluorescent intensity) against one or more donor HLA antigens
- Patient has undergone prior autologous or allogeneic stem cell transplant
- Requiring sedation for cardiac MRIs.
- Prohibited Implants and/or Devices:
- Mechanical, magnetic or electrical activated implants (i.e. cardiac pacemakers, neurostimulators and infusion pumps)
- Ferromagnetic implants and ferromagnetic foreign bodies, such as intracranial, aneurysm clips, shrapnel and intraocular metal chips as these could become dislodged.
- Subjects with claustrophobia, problems being in enclosed spaces, or inability to lie supine.
Where it is running
- Cedars-Sinai Medical Center — Los Angeles, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.